Stay updated on Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Sign up to get notified when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.

Latest updates to the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page
- Check4 days agoChange DetectedA banner announcing NIH’s terminology transition was added above the ClinicalTrials.gov page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study details and attached documents with a standard error page. This indicates an access restriction rather than a content update to the record.SummaryDifference18%

- Check39 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6. This appears to reflect a platform or template update rather than changes to the study data.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a revision bump from v3.6.5 to v3.6.6, indicating an updated deployment of the page. This appears to be a backend or formatting update rather than a modification to study data or content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe study record now includes an NIH grant/contract note in the funding/identifiers section, clarifying the source of support for the trial.SummaryDifference0.0%

Stay in the know with updates to Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adolescent Dapagliflozin Safety & Efficacy in T2DM Clinical Trial page.